Nanotherapy for Cancer: Targeting and Multi-functionality in the Future of Cancer Therapies. A Ediriwickrema, WM Saltzman ACS Biomaterials Science & Engineering 1 (2), 2015 | 211 | 2015 |
A sunblock based on bioadhesive nanoparticles Y Deng, A Ediriwickrema, F Yang, J Lewis, M Girardi, WM Saltzman Nature materials 14 (12), 1278-1285, 2015 | 179 | 2015 |
Single-cell mutational profiling enhances the clinical evaluation of AML MRD A Ediriwickrema, A Aleshin, JG Reiter, MR Corces, T Köhnke, M Stafford, ... Blood advances 4 (5), 943-952, 2020 | 76 | 2020 |
Multi-layered nanoparticles for combination gene and drug delivery to tumors A Ediriwickrema, J Zhou, Y Deng, WM Saltzman Biomaterials 35 (34), 9343-9354, 2014 | 66 | 2014 |
Successful treatment of thrombocytopenia with daratumumab after allogeneic transplant: a case report and literature review Y Migdady, A Ediriwickrema, RP Jackson, W Kadi, R Gupta, F Socola, ... Blood Advances 4 (5), 815, 2020 | 31 | 2020 |
Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experience A Azizi, A Ediriwickrema, R Dutta, SA Patel, W Shomali, B Medeiros, ... Leukemia & Lymphoma 61 (11), 2700-2707, 2020 | 25 | 2020 |
The Cell Type–Specific 5hmC Landscape and Dynamics of Healthy Human Hematopoiesis and TET2-Mutant Preleukemia Y Nakauchi, A Azizi, D Thomas, MR Corces, A Reinisch, R Sharma, ... Blood cancer discovery 3 (4), 346-367, 2022 | 21 | 2022 |
Single-cell genomics in AML: extending the frontiers of AML research A Ediriwickrema, AJ Gentles, R Majeti Blood 141 (4), 345-355, 2023 | 18 | 2023 |
Flow diverters and a tale of two aneurysms GA Kuzmik, T Williamson, A Ediriwickrema, A Andeejani, KR Bulsara Journal of NeuroInterventional Surgery 5 (4), e23-e23, 2013 | 18 | 2013 |
Clinico-genomic profiling and clonal dynamic modeling of TP53-aberrant myelodysplastic syndrome and acute myeloid leukemia SA Patel, MR Lloyd, J Cerny, Q Shi, K Simin, A Ediriwickrema, ... Leukemia & Lymphoma 62 (14), 3348-3360, 2021 | 17 | 2021 |
Intracranial stenting as monotherapy in subarachnoid hemorrhage and sickle cell disease A Ediriwickrema, T Williamson, R Hebert, C Matouk, MH Johnson, ... Journal of NeuroInterventional Surgery 5 (2), e4-e4, 2013 | 14 | 2013 |
Prognostic heterogeneity and clonal dynamics within distinct subgroups of myelodysplastic syndrome and acute myeloid leukemia with TP53 disruptions SA Patel, J Cerny, WK Gerber, M Ramanathan, A Ediriwickrema, ... EJHaem 4 (4), 1059-1070, 2023 | 6 | 2023 |
Peripheral blood DNA methylation profiles predict future development of B-cell Non-Hodgkin Lymphoma A Espín-Pérez, K Brennan, AS Ediriwickrema, O Gevaert, IS Lossos, ... NPJ precision oncology 6 (1), 53, 2022 | 5 | 2022 |
A case report of refractory immune thrombocytopenia (ITP) following reduced intensity conditioning (RIC) hematopoietic cell transplantation (HCT) for myelodysplastic syndrome … Y Migdady, R Gupta, A Ediriwickrema, F Socola, S Arai, BA Martin Blood 132, 4976, 2018 | 4 | 2018 |
Tissue plasminogen activator via cross-collateralization for tandem internal carotid and middle cerebral artery occlusion KR Bulsara, A Ediriwickrema, J Pepper, F Robertson, J Aruny, J Schindler World Journal of Clinical Cases: WJCC 1 (9), 290, 2013 | 4 | 2013 |
Topical formulation of hyperbranched polymer-coated particles Y Deng, A Ediriwickrema, WM Saltzman, M Girardi US Patent 11,918,695, 2024 | 3 | 2024 |
Hyperbranched polyglycerol-coated particles and methods of making and using thereof Y Deng, A Ediriwickrema, WM Saltzman US Patent 10,238,581, 2019 | 2 | 2019 |
Crescentic Glomerulonephritis With Immunoglobulin G4–Related Disease I Raber, A Ediriwickrema, J Higgins, N Kambham, AC Pao The American Journal of the Medical Sciences 354 (3), 236-239, 2017 | 2 | 2017 |
Convergent epigenetic evolution drives relapse in acute myeloid leukemia K Nuno, A Azizi, T Koehnke, C Lareau, A Ediriwickrema, MR Corces, ... Elife 13, e93019, 2024 | 1 | 2024 |
CD38 and BCL2 expression guides treatment with daratumumab and venetoclax in tagraxofusp-refractory blastic plasmacytoid dendritic cell neoplasm (BPDCN) featuring dynamic loss … X Hu, A Ediriwickrema, A Saleem, B Tan, N Pemmaraju, GN Mannis Leukemia Research 139, 107479, 2024 | 1 | 2024 |